79–006 

111TH CONGRESS REPORT " ! HOUSE OF REPRESENTATIVES 1st Session 111–47 

NATIONAL PAIN CARE POLICY ACT OF 2009 

MARCH 23, 2009.—Committed to the Committee of the Whole House on the State 

of the Union and ordered to be printed 

Mr. WAXMAN, from the Committee on Energy and Commerce, 

submitted the following 

R E P O R T 

[To accompany H.R. 756] 

[Including cost estimate of the Congressional Budget Office] 

The Committee on Energy and Commerce, to whom was referred 

the bill (H.R. 756) to amend the Public Health Service Act with respect to pain care, having considered the same, report favorably 

thereon without amendment and recommend that the bill do pass. 

CONTENTS 

Page 

Purpose and Summary ............................................................................................ 1 

Background and Need for Legislation .................................................................... 2 

Hearings ................................................................................................................... 2 

Committee Consideration ........................................................................................ 2 

Committee Votes ...................................................................................................... 2 

Committee Oversight Findings ............................................................................... 2 

Statement of General Performance Goals and Objectives .................................... 2 

New Budget Authority, Entitlement Authority, and Tax Expenditures ............. 3 

Earmarks and Tax and Tariff Benefits .................................................................. 3 

Committee Cost Estimate ....................................................................................... 3 

Congressional Budget Office Estimate ................................................................... 3 

Federal Mandates Statement ................................................................................. 5 

Advisory Committee Statement .............................................................................. 5 

Constitutional Authority Statement ...................................................................... 5 

Applicability to Legislative Branch ........................................................................ 5 

Section-by-Section Analysis of the Legislation ...................................................... 6 

Change in Existing Law Made by the Bill, As Reported ...................................... 8 

PURPOSE AND SUMMARY

The purpose of H.R. 756, the ‘‘National Pain Care Policy Act of 

2009’’, is to amend the Public Health Service Act with respect to 

pain care. The bill authorizes the Secretary of Health and Human 

Services to contract with the Institute of Medicine to convene a naVerDate Nov 24 2008 06:29 Mar 25, 2009 Jkt 079006 PO 00000 Frm 00001 Fmt 6659 Sfmt 6602 E:\HR\OC\HR047.XXX HR047

jbell on PROD1PC69 with REPORTS
2 

tional conference on pain; authorizes the Secretary to support programs to educate and train health professionals in pain care; and 

directs the Secretary to implement a national pain care education, 

outreach, and awareness campaign. The bill authorizes the appropriation of various amounts for each of these purposes for fiscal 

years 2010 through 2012. 

BACKGROUND AND NEED FOR LEGISLATION

Pain is the most common reason Americans access the health 

care system and is a leading cause of disability and major contributor to health care costs. The National Center for Health Statistics 

estimates that 76.2 million, or one in every four Americans, have 

suffered from pain that lasts longer than 24 hours and millions 

more suffer from acute pain. 

Most painful conditions can be relieved with proper treatment, 

and providing adequate pain management is a crucial component 

of improving and maintaining quality of life for patients, survivors, 

and their loved ones. People in pain, however, often face significant 

barriers that can prevent proper assessment, diagnosis, treatment, 

and management of their pain. Left untreated, pain can decrease 

the quality of life and affect every aspect of daily living, including 

work, sleep, and social relations. 

HEARINGS

The Committee on Energy and Commerce did not hold hearings 

on the legislation. 

COMMITTEE CONSIDERATION

The Committee on Energy and Commerce met in open markup 

session on Wednesday, March 4, 2009, and, pursuant to a motion 

by Mr. Waxman, agreed by unanimous consent to consider and approve H.R. 756 and several other bills en bloc. H.R. 756 was ordered favorably reported to the House by a voice vote. No amendments were offered during full Committee consideration of H.R. 

756. 

COMMITTEE VOTES

Clause 3(b) of rule XIII of the Rules of the House of Representatives requires the Committee to list the record votes on the motion 

to report legislation and amendments thereto. There were no recorded votes taken during consideration or ordering H.R. 756 reported to the House. 

COMMITTEE OVERSIGHT FINDINGS

Regarding clause 3(c)(1) of rule XIII of the Rules of the House 

of Representatives, the oversight findings of the Committee are reflected in this report. 

STATEMENT OF GENERAL PERFORMANCE GOALS AND OBJECTIVES

The objective of H.R. 756 is to amend the Public Health Service 

Act to (1) encourage the Secretary of Health and Human Services 

(HHS) to enter into an agreement with the Institute of Medicine 

(IOM) of the National Academies to convene a Conference on Pain; 


jbell on PROD1PC69 with REPORTS
3 

(2) encourage the Director of the National Institutes of Health 

(NIH) to continue to expand, through the Pain Consortium, an aggressive program of basic and clinical research on the causes of and 

potential treatments for pain; (3) establish an Interagency Pain Research Coordinating Committee within HHS; (4) allow the Secretary to award grants, cooperative agreements, and contracts to 

health professions schools, hospices, and other public and private 

entities for the development and implementation of programs to 

provide education and training to health care professionals in pain 

care; and (5) require the Secretary to establish and implement a 

national pain care education outreach and awareness campaign. 

NEW BUDGET AUTHORITY, ENTITLEMENT AUTHORITY, AND TAX

EXPENDITURES

Regarding compliance with clause 3(c)(2) of rule XIII of the Rules 

of the House of Representatives, the Committee finds that H.R. 756 

would result in no new or increased budget authority, entitlement 

authority, or tax expenditures or revenues. 

EARMARKS AND TAX AND TARIFF BENEFITS

In compliance with clause 9 of rule XXI of the Rules of the House 

of Representatives, H.R. 756 does not contain any congressional 

earmarks, limited tax benefits, or limited tariff benefits as defined 

in clause 9(d), 9(e), or 9(f) of rule XXI. 

COMMITTEE COST ESTIMATE

The Committee adopts as its own the cost estimate on H.R. 756 

prepared by the Director of the Congressional Budget Office pursuant to section 402 of the Congressional Budget Act of 1974. 

CONGRESSIONAL BUDGET OFFICE ESTIMATE

Pursuant to clause 3(c)(3) of rule XIII of the Rules of the House 

of Representatives, the following is the cost estimate on H.R. 756 

provided by the Congressional Budget Office pursuant to section 

402 of the Congressional Budget Act of 1974: 

U.S. CONGRESS, 

CONGRESSIONAL BUDGET OFFICE, 

Washington, DC, March 20, 2009. 

Hon. HENRY A. WAXMAN, Chairman, Committee on Energy and Commerce, 

House of Representatives, Washington, DC. 

DEAR MR. CHAIRMAN: The Congressional Budget Office has prepared the enclosed cost estimate for H.R. 756, the National Pain 

Care Policy Act of 2009. 

If you wish further details on this estimate, we will be pleased 

to provide them. The CBO staff contact is Stephanie Cameron. 

Sincerely, 

DOUGLAS W. ELMENDORF, 

Director. 

Enclosure. 


jbell on PROD1PC69 with REPORTS
4 

H.R. 1246—Early Hearing Detection and Intervention Act of 2009 

Summary: H.R. 1246 would amend the Public Health Service Act 

to authorize and expand research and public health activities related to the early detection, diagnosis, and treatment of hearing 

loss in newborns and infants. CBO estimates that implementing 

the bill would cost $151 million over the 2010–2014 period, assuming appropriation of the necessary amounts. Enacting H.R. 1246 

would not affect direct spending or revenues. 

H.R. 1246 contains no intergovernmental or private-sector mandates as defined in the Unfunded Mandates Reform Act (UMRA). 

Estimated cost to the Federal Government: The estimated budgetary impact of H.R. 1246 is shown in the following table. The costs 

of this legislation fall within budget function 550 (health). 

By fiscal year, in millions of dollars— 

2010 2011 2012 2013 2014 2010– 

2014 

CHANGES IN SPENDING SUBJECT TO APPROPRIATION 

HRSA: 

Estimated Authorization Level ......................................................... 12 12 12 12 12 61 

Estimated Outlays ........................................................................... 6 11 12 12 12 53 

CDC: 

Estimated Authorization Level ......................................................... 11 11 11 11 11 55 

Estimated Outlays ........................................................................... 4 9 11 11 11 46 

NIH: 

Estimated Authorization Level ......................................................... 13 13 13 13 13 64 

Estimated Outlays ........................................................................... 3 11 12 13 13 51 

Total Changes: 

Estimated Authorization Level ......................................................... 36 36 36 36 36 180 

Estimated Outlays ........................................................................... 14 30 35 36 36 151 

Note: CDC = Centers for Disease Control and Prevention. HRSA = Health Resources and Services Administration. NIH = National Institutes of Health. 

Basis of estimate: H.R. 1246 would authorize funding for early 

hearing loss detection and intervention activities at the Health Resources and Services Administration (HRSA), the Centers for Disease Control and Prevention (CDC), and the National Institutes of 

Health (NIH) for fiscal years 2010 through 2015. It also would require the Director of the National Institutes of Health to establish 

a postdoctoral research program to foster research and development in the area of early hearing detection and intervention. CBO 

estimates that those activities would require the appropriation of 

$180 million over the 2010–2014 period. Based on historical spending patterns for similar activities and assuming the appropriation 

of necessary amounts, CBO estimates that implementing H.R. 1246 

would cost $151 million over the 2010–2014 period. 

HRSA administers the Universal Newborn Screening program, 

which makes grants to states to support testing of infants prior to 

hospital discharge, audiologic evaluation by three months of age, 

and early intervention activities. CBO estimates that those activities would require the appropriation of $61 million over the 2010– 

2014 period. Assuming the appropriation of the necessary amounts, 

CBO estimates that implementing that grant program would cost 

$53 million over the 2010–2014 period. 

H.R. 1246 would authorize CDC to make grants to states and 

provide technical assistance to states to promote screening, surveillance, and research into the causes of hearing loss among newborns 

and infants. To fund that grant program, CBO estimates that the 


jbell on PROD1PC69 with REPORTS
5 

CDC would require the appropriation of $55 million over the 2010– 

2014 period. Assuming the appropriation of the necessary amounts, 

CBO estimates that implementing the program would cost $46 million over the 2010–2014 period. 

H.R. 1246 would authorize the NIH to conduct research on early 

detection and treatment of hearing loss. The bill would direct the 

NIH to establish a postdoctoral fellowship program to train researchers in the field of detecting and intervening in early hearing 

loss. Based on information provided by the NIH, CBO expects that 

the new postdoctoral program would fund three postdoctoral fellows at an annual cost of approximately $120,000 per fellow. Based 

on that information, historical program expenditures at NIH, and 

adjustments for inflation, CBO estimates that NIH would require 

the appropriation of $64 million over the 2010–2014 period. CBO 

estimates that implementing those programs would cost $51 million over the 2010–2014 period, assuming appropriation of the necessary amounts. 

Intergovernmental and private-sector impact: H.R. 1246 contains 

no intergovernmental or private-sector mandates as defined in 

UMRA. States that participate in programs to detect, diagnose, and 

treat hearing loss in newborns and infants would benefit from activities and grants authorized in the bill. 

Estimate prepared by: Federal Costs: Jamease Kowalczyk, Stephanie Cameron, and Lisa Ramirez-Branum; Impact on State, Local, 

and Tribal Governments: Lisa Ramirez-Branum; Impact on Private 

Sector: Patrick Bernhardt. 

Estimate approved by: Peter H. Fontaine, Assistant Director for 

Budget Analysis. 

FEDERAL MANDATES STATEMENT

The Committee adopts as its own the estimate of federal mandates regarding H.R. 756 prepared by the Director of the Congressional Budget Office pursuant to section 423 of the Unfunded Mandates Reform Act. 

ADVISORY COMMITTEE STATEMENT

No advisory committees within the meaning of section 5(b) of the 

Federal Advisory Committee Act were created by H.R. 756. 

CONSTITUTIONAL AUTHORITY STATEMENT

Pursuant to clause 3(d)(1) of rule XIII of the Rules of the House 

of Representatives, the Committee finds that the constitutional authority for H.R. 756 is provided in the provisions of Article I, section 8, clause 1, that relate to expending funds to provide for the 

general welfare of the United States. 

APPLICABILITY TO LEGISLATIVE BRANCH

The Committee finds that H.R. 756 does not relate to the terms 

and conditions of employment or access to public services or accommodations within the meaning of section 102(b)(3) of the Congressional Accountability Act of 1995. 


jbell on PROD1PC69 with REPORTS
6 

SECTION-BY-SECTION ANALYSIS OF THE LEGISLATION

Section 1. Short title 

Section 1 establishes the short title of the bill as the ‘‘National 

Pain Care Policy Act of 2009’’ and lists the table of contents. 

Section 2. Institute of Medicine Conference on Pain 

Section 2 states that, no later than June 30, 2010, the Secretary 

must seek to enter into an agreement with the IOM of the National 

Academies to convene a conference on pain. The purpose of the conference shall be to increase the recognition of pain as a significant 

public health problem in the United States; evaluate the adequacy 

of assessment, diagnosis, treatment, and management of acute and 

chronic pain in the general population; identify racial, ethnic, gender, age, and other demographic groups that may be disproportionately affected by inadequacies in the system; identify barriers to 

appropriate pain care; and establish an agenda for action in both 

the public and private sectors that will reduce such barriers and 

significantly improve the state of pain care research, education, 

and clinical care in the United States. 

If the Institute of Medicine declines to enter into this agreement, 

the Secretary may enter into such agreement with another appropriate entity. 

Section 2 requires that a report summarizing the conference’s 

findings shall be submitted to Congress no later than June 30, 

2011. 

For the purpose of carrying out section 2, this legislation authorizes to be appropriated $500,000 for each of fiscal years 2010 and 

2011. 

Section 3. Pain research at National Institutes of Health 

Section 3 amends part B of title IV of the Public Health Service 

Act (42 U.S.C. 284 et seq.) by adding a new section, section 409J. 

Section 409J. Pain research 

Section 409J encourages the NIH Director to continue and expand, through the pain consortium, an aggressive program of basic 

and clinical research on the causes of and potential treatments for 

pain. At least once a year, the pain consortium, in consultation 

with the Division of Program Coordination, Planning, and Strategic 

Initiatives, shall develop and submit to the NIH Director recommendations on appropriate pain research initiatives that could 

be undertaken with funds reserved for the common fund or otherwise available for such initiatives. 

Section 409J defines the term ‘‘pain consortium’’ to mean the 

pain consortium of NIH or a similar trans-NIH coordinating entity 

designated by the Secretary. 

Section 409J directs the Secretary to establish an interagency 

pain research coordinating committee, charged with coordinating 

all efforts within HHS and other federal agencies that relate to 

pain research. This section establishes the composition of the coordinating committee and requires that the committee meet at the 

call of the chairperson, or upon the request of the NIH Director, 

but in no case less often than once per year. 


jbell on PROD1PC69 with REPORTS
7 

Section 409J establishes the duties of the coordinating committee 

and requires the committee to develop a summary of advances in 

pain care research supported or conducted by the federal agencies 

relevant to the diagnosis, treatment, and prevention of pain, and 

diseases and disorders associated with pain; identify critical gaps 

in basic and clinical research on the symptoms and causes of pain; 

and make recommendations. The Secretary shall review the necessity of the committee at least once every two years. 

Section 4. Pain care education and training 

Section 4 amends part D of title VII of the Public Health Service 

Act (42 U.S.C. 294 et seq.) by adding a new section, section 754, 

and redesignating sections 754 through 758 as sections 755 

through 759, respectively. 

Section 754. Program for education and training in pain care 

Section 754 states that the Secretary may award grants, cooperative agreements, and contracts to health professions schools, hospices, and other public and private entities for the development 

and implementation of programs to provide education and training 

to health care professionals in pain care. 

Section 754 states that an award may be made only if the applicant for the award agrees that the program carried out with the 

award will include information and education on recognized means 

for assessing, diagnosing, treating, and managing pain and related 

signs and symptoms, including the medically appropriate use of 

controlled substances. In addition, programs carried out must include information and education on applicable laws, regulations, 

rules, and policies on controlled substances; interdisciplinary approaches to the delivery of pain care; cultural, linguistic, literacy, 

geographic, and other barriers to care in underserved populations; 

and recent findings, developments, and improvements in the provision of pain care. This section requires the Secretary to provide for 

the evaluation of these programs in order to determine the effect 

of such programs on the knowledge and practice of pain care. 

Section 754 defines the term ‘‘pain care’’ to mean the assessment, 

diagnosis, treatment, or management of acute or chronic pain regardless of causation or body location. 

Section 754 updates the existing authorization of appropriations 

to require that, of the amounts appropriated for a fiscal year, the 

Secretary shall make available not less than $5,000,000 for awards 

of grants, cooperative agreements, and contracts under this section. 

Section 754 also makes conforming amendments to sections 757(b) 

and 758(b)(1). 

Section 5. Public awareness campaign on pain management 

Section 5 amends part B of title II of the Public Health Service 

Act (42 U.S.C. 238 et seq.) by adding a new section, Section 249. 

Section 249. National education outreach and awareness 

campaign on pain management 

Section 249 requires that, no later than June 30, 2010, the Secretary shall establish and implement a national pain care education outreach and awareness campaign. Amongst other things, 

the public awareness campaign shall be designed to educate conVerDate Nov 24 2008 06:29 Mar 25, 2009 Jkt 079006 PO 00000 Frm 00007 Fmt 6659 Sfmt 6602 E:\HR\OC\HR047.XXX HR047

jbell on PROD1PC69 with REPORTS
8 

sumers, patients, their families, and other caregivers with respect 

to the incidence and importance of pain as a national public health 

problem. In designing and implementing the public awareness campaign, the Secretary shall consult with organizations representing 

patients in pain and other consumers, employers, physicians, other 

pain management professionals, medical device manufacturers, and 

pharmaceutical companies. 

Section 249 requires the Secretary to designate one official in 

HHS to oversee the public awareness campaign and to ensure the 

involvement of the Surgeon General of the Public Health Service, 

the Director of the Centers for Disease Control and Prevention, and 

other such representatives of offices and agencies of HHS as the 

Secretary determines appropriate. 

Section 249 requires that, in designing the public awareness 

campaign, the Secretary shall take into account the special needs 

of geographic areas and racial, ethnic, gender, age, and other demographic groups that are currently underserved and provide resources that will reduce disparities in access to appropriate diagnosis, assessment, and treatment. 

Under this section, the Secretary has discretionary authority to 

make awards of grants, cooperative agreements, and contracts to 

public agencies and private nonprofit organizations to assist with 

the development and implementation of the public awareness campaign. In addition, the Secretary shall prepare and submit a report 

to Congress evaluating the effectiveness of the public awareness 

campaign in educating the general public. 

For purposes of carrying out section 249, there is authorized to 

be appropriated $2,000,000 for fiscal year 2010 and $4,000,000 for 

each of fiscal years 2011 and 2012. 

CHANGES IN EXISTING LAW MADE BY THE BILL, AS REPORTED

In compliance with clause 3(e) of rule XIII of the Rules of the 

House of Representatives, changes in existing law made by the bill, 

as reported, are shown as follows (existing law proposed to be omitted is enclosed in black brackets, new matter is printed in italic, 

existing law in which no change is proposed is shown in roman): 

PUBLIC HEALTH SERVICE ACT 

* * * * * * * 

TITLE II—ADMINISTRATION AND MISCELLANEOUS 

PROVISIONS 

* * * * * * * 

PART B—MISCELLANEOUS PROVISIONS

* * * * * * * 

SEC. 249. NATIONAL EDUCATION OUTREACH AND AWARENESS CAMPAIGN ON PAIN MANAGEMENT. 

(a) ESTABLISHMENT.—Not later than June 30, 2010, the Secretary 

shall establish and implement a national pain care education outreach and awareness campaign described in subsection (b). 


jbell on PROD1PC69 with REPORTS
9 

(b) REQUIREMENTS.—The Secretary shall design the public awareness campaign under this section to educate consumers, patients, 

their families, and other caregivers with respect to— 

(1) the incidence and importance of pain as a national public 

health problem; 

(2) the adverse physical, psychological, emotional, societal, 

and financial consequences that can result if pain is not appropriately assessed, diagnosed, treated, or managed; 

(3) the availability, benefits, and risks of all pain treatment 

and management options; 

(4) having pain promptly assessed, appropriately diagnosed, 

treated, and managed, and regularly reassessed with treatment 

adjusted as needed; 

(5) the role of credentialed pain management specialists and 

subspecialists, and of comprehensive interdisciplinary centers of 

treatment expertise; 

(6) the availability in the public, nonprofit, and private sectors of pain management-related information, services, and resources for consumers, employers, third-party payors, patients, 

their families, and caregivers, including information on— 

(A) appropriate assessment, diagnosis, treatment, and 

management options for all types of pain and pain-related 

symptoms; and 

(B) conditions for which no treatment options are yet recognized; and 

(7) other issues the Secretary deems appropriate. 

(c) CONSULTATION.—In designing and implementing the public 

awareness campaign required by this section, the Secretary shall 

consult with organizations representing patients in pain and other 

consumers, employers, physicians including physicians specializing 

in pain care, other pain management professionals, medical device 

manufacturers, and pharmaceutical companies. 

(d) COORDINATION.— (1) LEAD OFFICIAL.—The Secretary shall designate one official 

in the Department of Health and Human Services to oversee the 

campaign established under this section. 

(2) AGENCY COORDINATION.—The Secretary shall ensure the 

involvement in the public awareness campaign under this section of the Surgeon General of the Public Health Service, the 

Director of the Centers for Disease Control and Prevention, and 

such other representatives of offices and agencies of the Department of Health and Human Services as the Secretary determines appropriate. 

(e) UNDERSERVED AREAS AND POPULATIONS.—In designing the 

public awareness campaign under this section, the Secretary shall— 

(1) take into account the special needs of geographic areas 

and racial, ethnic, gender, age, and other demographic groups 

that are currently underserved; and 

(2) provide resources that will reduce disparities in access to 

appropriate diagnosis, assessment, and treatment. 

(f) GRANTS AND CONTRACTS.—The Secretary may make awards of 

grants, cooperative agreements, and contracts to public agencies and 

private nonprofit organizations to assist with the development and 

implementation of the public awareness campaign under this section. 


jbell on PROD1PC69 with REPORTS
10 

(g) EVALUATION AND REPORT.—Not later than the end of fiscal 

year 2012, the Secretary shall prepare and submit to the Congress 

a report evaluating the effectiveness of the public awareness campaign under this section in educating the general public with respect to the matters described in subsection (b). 

(h) AUTHORIZATION OF APPROPRIATIONS.—For purposes of carrying out this section, there are authorized to be appropriated 

$2,000,000 for fiscal year 2010 and $4,000,000 for each of fiscal 

years 2011 and 2012. 

* * * * * * * 

TITLE IV—NATIONAL RESEARCH INSTITUTES 

* * * * * * * 

PART B—GENERAL PROVISIONS RESPECTING NATIONAL RESEARCH

INSTITUTES

* * * * * * * 

SEC. 409J. PAIN RESEARCH. 

(a) RESEARCH INITIATIVES.— 

(1) IN GENERAL.—The Director of NIH is encouraged to continue and expand, through the Pain Consortium, an aggressive 

program of basic and clinical research on the causes of and potential treatments for pain. 

(2) ANNUAL RECOMMENDATIONS.—Not less than annually, the 

Pain Consortium, in consultation with the Division of Program 

Coordination, Planning, and Strategic Initiatives, shall develop 

and submit to the Director of NIH recommendations on appropriate pain research initiatives that could be undertaken with 

funds reserved under section 402A(c)(1) for the Common Fund 

or otherwise available for such initiatives. 

(3) DEFINITION.—In this subsection, the term ‘‘Pain Consortium’’ means the Pain Consortium of the National Institutes of 

Health or a similar trans-National Institutes of Health coordinating entity designated by the Secretary for purposes of this 

subsection. 

(b) INTERAGENCY PAIN RESEARCH COORDINATING COMMITTEE.— 

(1) ESTABLISHMENT.—The Secretary shall establish not later 

than 1 year after the date of the enactment of this section and 

as necessary maintain a committee, to be known as the Interagency Pain Research Coordinating Committee (in this section 

referred to as the ‘‘Committee’’), to coordinate all efforts within 

the Department of Health and Human Services and other Federal agencies that relate to pain research. 

(2) MEMBERSHIP.— 

(A) IN GENERAL.—The Committee shall be composed of 

the following voting members: 

(i) Not more than 7 voting Federal representatives as 

follows: 

(I) The Director of the Centers for Disease Control and Prevention. 

(II) The Director of the National Institutes of 

Health and the directors of such national research 


jbell on PROD1PC69 with REPORTS
11 

institutes and national centers as the Secretary determines appropriate. 

(III) The heads of such other agencies of the Department of Health and Human Services as the 

Secretary determines appropriate. 

(IV) Representatives of other Federal agencies 

that conduct or support pain care research and 

treatment, including the Department of Defense 

and the Department of Veterans Affairs. 

(ii) 12 additional voting members appointed under 

subparagraph (B). 

(B) ADDITIONAL MEMBERS.—The Committee shall include 

additional voting members appointed by the Secretary as 

follows: 

(i) 6 members shall be appointed from among scientists, physicians, and other health professionals, 

who— 

(I) are not officers or employees of the United 

States; 

(II) represent multiple disciplines, including 

clinical, basic, and public health sciences; 

(III) represent different geographical regions of 

the United States; and 

(IV) are from practice settings, academia, manufacturers or other research settings; and 

(ii) 6 members shall be appointed from members of 

the general public, who are representatives of leading 

research, advocacy, and service organizations for individuals with pain-related conditions. 

(C) NONVOTING MEMBERS.—The Committee shall include 

such nonvoting members as the Secretary determines to be 

appropriate. 

(3) CHAIRPERSON.—The voting members of the Committee 

shall select a chairperson from among such members. The selection of a chairperson shall be subject to the approval of the Director of NIH. 

(4) MEETINGS.—The Committee shall meet at the call of the 

chairperson of the Committee or upon the request of the Director 

of NIH, but in no case less often than once each year. 

(5) DUTIES.—The Committee shall— 

(A) develop a summary of advances in pain care research 

supported or conducted by the Federal agencies relevant to 

the diagnosis, prevention, and treatment of pain and diseases and disorders associated with pain; 

(B) identify critical gaps in basic and clinical research on 

the symptoms and causes of pain; 

(C) make recommendations to ensure that the activities of 

the National Institutes of Health and other Federal agencies, including the Department of Defense and the Department of Veteran Affairs, are free of unnecessary duplication 

of effort; 

(D) make recommendations on how best to disseminate 

information on pain care; and 

(E) make recommendations on how to expand partnerships between public entities, including Federal agencies, 


jbell on PROD1PC69 with REPORTS
12 

and private entities to expand collaborative, cross-cutting 

research. 

(6) REVIEW.—The Secretary shall review the necessity of the 

Committee at least once every 2 years. 

* * * * * * * 

TITLE VII—HEALTH PROFESSIONS 

EDUCATION 

* * * * * * * 

PART D—INTERDISCIPLINARY, COMMUNITYBASED LINKAGES 

* * * * * * * 

SEC. 754. PROGRAM FOR EDUCATION AND TRAINING IN PAIN CARE. 

(a) IN GENERAL.—The Secretary may make awards of grants, cooperative agreements, and contracts to health professions schools, 

hospices, and other public and private entities for the development 

and implementation of programs to provide education and training 

to health care professionals in pain care. 

(b) PRIORITIES.—In making awards under subsection (a), the Secretary shall give priority to awards for the implementation of programs under such subsection. 

(c) CERTAIN TOPICS.—An award may be made under subsection 

(a) only if the applicant for the award agrees that the program carried out with the award will include information and education 

on— 

(1) recognized means for assessing, diagnosing, treating, and 

managing pain and related signs and symptoms, including the 

medically appropriate use of controlled substances; 

(2) applicable laws, regulations, rules, and policies on controlled substances, including the degree to which misconceptions and concerns regarding such laws, regulations, rules, and 

policies, or the enforcement thereof, may create barriers to patient access to appropriate and effective pain care; 

(3) interdisciplinary approaches to the delivery of pain care, 

including delivery through specialized centers providing comprehensive pain care treatment expertise; 

(4) cultural, linguistic, literacy, geographic, and other barriers to care in underserved populations; and 

(5) recent findings, developments, and improvements in the 

provision of pain care. 

(d) PROGRAM SITES.—Education and training under subsection 

(a) may be provided at or through health professions schools, residency training programs, and other graduate programs in the 

health professions; entities that provide continuing education in 

medicine, pain management, dentistry, psychology, social work, 

nursing, and pharmacy; hospices; and such other programs or sites 

as the Secretary determines to be appropriate. 

(e) EVALUATION OF PROGRAMS.—The Secretary shall (directly or 

through grants or contracts) provide for the evaluation of programs 


jbell on PROD1PC69 with REPORTS
13 

implemented under subsection (a) in order to determine the effect of 

such programs on knowledge and practice of pain care. 

(f) PEER REVIEW GROUPS.—In carrying out section 799(f) with respect to this section, the Secretary shall ensure that the membership 

of each peer review group involved includes individuals with expertise and experience in pain care. 

(g) DEFINITIONS.—For purposes of this section the term ‘‘pain 

care’’ means the assessment, diagnosis, treatment, or management of 

acute or chronic pain regardless of causation or body location. 

SEC. ø754.¿ 755. QUENTIN N. BURDICK PROGRAM FOR RURAL INTERDISCIPLINARY TRAINING. 

(a) * * * 

* * * * * * * 

SEC. ø755.¿ 756. ALLIED HEALTH AND OTHER DISCIPLINES. 

(a) * * * 

* * * * * * * 

SEC. ø756.¿ 757. ADVISORY COMMITTEE ON INTERDISCIPLINARY, COMMUNITY-BASED LINKAGES. 

(a) * * * 

(b) COMPOSITION.— (1) * * * 

(2) APPOINTMENT.—Not later than 90 days after the date of 

enactment of this Act, the Secretary shall appoint the members 

of the Advisory Committee from among individuals who are 

health professionals from schools of the types described in sections 751(a)(1)(A), 751(a)(1)(B), 753(b), ø754(3)(A), and 755(b)¿ 

755(3)(A), and 756(b). In making such appointments, the Secretary shall ensure a fair balance between the health professions, that at least 75 percent of the members of the Advisory 

Committee are health professionals, a broad geographic representation of members and a balance between urban and 

rural members. Members shall be appointed based on their 

competence, interest, and knowledge of the mission of the profession involved. 

* * * * * * * 

SEC. ø757.¿ 758. AUTHORIZATION OF APPROPRIATIONS. 

(a) * * * 

(b) ALLOCATION.— 

(1) IN GENERAL.—Of the amounts appropriated under subsection (a) for a fiscal year, the Secretary shall make available— 

(A) * * * 

(B) not less than $3,765,000 for awards of grants and 

contracts under section 752, of which not less than 50 percent of such amount shall be made available for centers 

described in subsection (a)(1) of such section; øand¿ 

(C) not less than $22,631,000 for awards of grants and 

contracts under sections 753, ø754, and 755.¿ 755, and 

756; and 

(D) not less than $5,000,000 for awards of grants, cooperative agreements, and contracts under sections 754. 

* * * * * * * 


jbell on PROD1PC69 with REPORTS
14 

SEC. ø758.¿ 759. INTERDISCIPLINARY TRAINING AND EDUCATION ON 

DOMESTIC VIOLENCE AND OTHER TYPES OF VIOLENCE 

AND ABUSE. 

(a) * * * 

* * * * * * * 

Æ 


jbell on PROD1PC69 with REPORTS